OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 45
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 27
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 27
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 27
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 27
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 26
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 26
Nanozyme-based synergistic therapeutic strategies against tumors
Ye Zhang, Ning Zhang, Shouping Gong, et al.
Drug Discovery Today (2025), pp. 104292-104292
Closed Access
Ye Zhang, Ning Zhang, Shouping Gong, et al.
Drug Discovery Today (2025), pp. 104292-104292
Closed Access
Basic helix–loop–helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases
Fanglin Shao, Zhipeng Wang, Luxia Ye, et al.
Burns & Trauma (2025) Vol. 13
Open Access
Fanglin Shao, Zhipeng Wang, Luxia Ye, et al.
Burns & Trauma (2025) Vol. 13
Open Access
A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: a universal model for multifunctional lung cancer therapy
Zhonglei Wang, Wenjing Xu, Shizeng Lei, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 250, pp. 114557-114557
Closed Access
Zhonglei Wang, Wenjing Xu, Shizeng Lei, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 250, pp. 114557-114557
Closed Access
Advances in controlled release drug delivery systems based on nanomaterials in lung cancer therapy: A review
Jiang Fu, Li Yu, Zixu Wang, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e41415-e41415
Open Access
Jiang Fu, Li Yu, Zixu Wang, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e41415-e41415
Open Access
Hybrid hydrogels based on agarose, halloysite nanotubes and polyvinyl alcohol: An excellent nanocarrier for controlled release of 5-fluorouracil
Negar Abbaszadeh Garousi, Mehrab Pourmadadi, Majid Abdouss, et al.
Hybrid Advances (2024) Vol. 5, pp. 100139-100139
Open Access | Times Cited: 5
Negar Abbaszadeh Garousi, Mehrab Pourmadadi, Majid Abdouss, et al.
Hybrid Advances (2024) Vol. 5, pp. 100139-100139
Open Access | Times Cited: 5
Graphene Oxide (GO) for the Treatment of Bone Cancer: A Systematic Review and Bibliometric Analysis
Lemy Vanessa Barba-Rosado, Domingo César Carrascal-Hernández, Daniel Insuasty, et al.
Nanomaterials (2024) Vol. 14, Iss. 2, pp. 186-186
Open Access | Times Cited: 5
Lemy Vanessa Barba-Rosado, Domingo César Carrascal-Hernández, Daniel Insuasty, et al.
Nanomaterials (2024) Vol. 14, Iss. 2, pp. 186-186
Open Access | Times Cited: 5
Recent advances in 3D bioprinting for cancer research: From precision models to personalized therapies
Ruchika, Neha Bhardwaj, Sudesh Kumar Yadav, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103924-103924
Closed Access | Times Cited: 5
Ruchika, Neha Bhardwaj, Sudesh Kumar Yadav, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103924-103924
Closed Access | Times Cited: 5
“On/off”-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX
Shuaijun Li, Caiting Meng, Qian Hao, et al.
Biomaterials (2024) Vol. 307, pp. 122537-122537
Closed Access | Times Cited: 5
Shuaijun Li, Caiting Meng, Qian Hao, et al.
Biomaterials (2024) Vol. 307, pp. 122537-122537
Closed Access | Times Cited: 5
Inorganic nanoparticle-cored dendrimers for biomedical applications: A review
Sepand Tehrani Fateh, Amir Hossein Aghaii, Zahra Aminzade, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29726-e29726
Open Access | Times Cited: 5
Sepand Tehrani Fateh, Amir Hossein Aghaii, Zahra Aminzade, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29726-e29726
Open Access | Times Cited: 5
Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 5
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 5
Revolutionizing cancer therapy: nanoformulation of miRNA-34 – enhancing delivery and efficacy for various cancer immunotherapies: a review
Marola Paula Fawzy, Hatem A. F. M. Hassan, Nada K. Sedky, et al.
Nanoscale Advances (2024)
Open Access | Times Cited: 5
Marola Paula Fawzy, Hatem A. F. M. Hassan, Nada K. Sedky, et al.
Nanoscale Advances (2024)
Open Access | Times Cited: 5
Enigmatic exosomal connection in lung cancer drug resistance
Sambit K. Patra, Rajeev Kumar Sahoo, Stuti Biswal, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102177-102177
Open Access | Times Cited: 4
Sambit K. Patra, Rajeev Kumar Sahoo, Stuti Biswal, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102177-102177
Open Access | Times Cited: 4
Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma
Na Xu, Jingliang Wu, Weihao Wang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2386-2402
Closed Access | Times Cited: 3
Na Xu, Jingliang Wu, Weihao Wang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2386-2402
Closed Access | Times Cited: 3
Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System
Haiqing Wang, Wentao Bo, Xielin Feng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5581-5603
Open Access | Times Cited: 3
Haiqing Wang, Wentao Bo, Xielin Feng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5581-5603
Open Access | Times Cited: 3
Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment
Fengzhi Zhao, Wei Huang, Lizhen He, et al.
Nano Today (2023) Vol. 50, pp. 101819-101819
Closed Access | Times Cited: 11
Fengzhi Zhao, Wei Huang, Lizhen He, et al.
Nano Today (2023) Vol. 50, pp. 101819-101819
Closed Access | Times Cited: 11
Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review
HafizMuhammad Imran, Yixin Tang, Siyuan Wang, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 31-31
Open Access | Times Cited: 8
HafizMuhammad Imran, Yixin Tang, Siyuan Wang, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 31-31
Open Access | Times Cited: 8
Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer
Zhongpeng Xie, Yanxia Wang, Ting-Fei Chen, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101117-101117
Closed Access | Times Cited: 2
Zhongpeng Xie, Yanxia Wang, Ting-Fei Chen, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101117-101117
Closed Access | Times Cited: 2
Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis
Qiushuo Zong, Chengyi He, Binbin Long, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1504-1504
Open Access | Times Cited: 2
Qiushuo Zong, Chengyi He, Binbin Long, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1504-1504
Open Access | Times Cited: 2
6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells
Jun Wu, Yong Chen, Hui Zou, et al.
Cancer Letters (2024) Vol. 601, pp. 217177-217177
Open Access | Times Cited: 2
Jun Wu, Yong Chen, Hui Zou, et al.
Cancer Letters (2024) Vol. 601, pp. 217177-217177
Open Access | Times Cited: 2
Metal-based nanocomposites for immunotherapy of osteosarcoma
Puhua Hao, Lulu Yang, Yichen Yan, et al.
Advanced Composites and Hybrid Materials (2024) Vol. 7, Iss. 6
Closed Access | Times Cited: 2
Puhua Hao, Lulu Yang, Yichen Yan, et al.
Advanced Composites and Hybrid Materials (2024) Vol. 7, Iss. 6
Closed Access | Times Cited: 2
Nano-engineering nanomedicines with customized functions for tumor treatment applications
Yuxin Wang, Shimei Li, Xiangling Ren, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Yuxin Wang, Shimei Li, Xiangling Ren, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
